Skip to main content
. 2022 Nov 28;12:1064462. doi: 10.3389/fcimb.2022.1064462

Table 2.

Patient characteristics.

Variables Control (n=12) NEC (n=12) χ2/Z/t P value
Gestational age, ¯x ± SD, w 31.7 ± 2.32 31.33 ± 2.1 -0.409 0.687
Birth weight, ¯x ± SD, g 1720.83 ± 541.32 1577.08 ± 575.26 -0.63 0.535
Female, % (n) 33.3(4) 25(3) / 1.000
Vaginal delivery, %(n) 41.7(5) 33.3(4) / 1.000
Intrauterine distress, %(n) 25(3) 8.3(1) / 0.590
Apgar 1 min, M (IQR) 8(6.25-9) 8.5(7.25-9) -0.521 0.630
Age at enrollment, M (IQR), d 7(3-16.5) 17(9.25-31.5) -1.937 0.052
CGA at enrollment, ¯x ± SD, w 33.43 ± 2.36 34.36 ± 2.09 1.021 0.318
Breast feeding, %(n) 58.3(7) 41.7(5) / 0.684
Antibiotic exposure during sample collection, %(n) 41.7(5) 41.7(5) / 1.000
PROM, %(n) 25(3) 33.3(4) / 1.000
Chorioamnionitis, %(n) 8.3(1) 8.3(1) / 1.000
GDM, % (n) 25(3) 41.7(5) / 0.667
Surgical treatment, %(n) 0.0(0) 33.3(4) / 0.093

NEC, necrotizing enterocolitis; IQR, interquartile range; CGA, corrected gestational age; PROM, premature rupture of membranes>18h;GDM, gestational diabetes mellitus.